Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Preclinical results indicate potential value of clevudine in chronic HBV infections

April 9, 1999

Neurokinin antagonists from Solvay particularly useful for GI disorders

April 9, 1999

Phase III trial of Aliminase in ulcerative colitis initiated

April 9, 1999

VRT-21493: a representative new HCV NS3 protease inhibitor designed by Vertex

April 8, 1999

Available for licensing from NIH: cloned genomes of infectious HCV and uses thereof

April 8, 1999

Nabi receives FDA approval, launches anti-hepatitis B product

April 5, 1999

SciClone receives another approval for Zadaxin

April 1, 1999

S-0509 exhibits potent gastric acid antisecretory effects in animal models

March 31, 1999

Enrollment completed for trial of InKine purgative tablets

March 29, 1999

Lilly and Ribozyme to collaborate on new HCV treatment

March 26, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...